Platelet distribution width-a prognosis marker in patients with chronic heart failure

Ana Neves1, Rita Gouveia1, Sérgio Madureira1

  • 1Internal Medicine Department, Unidade Local de Saúde São João, Porto, Portugal.

Porto Biomedical Journal
|January 9, 2025
PubMed

Insights

High platelet distribution width (PDW) levels are associated with an increased risk of all-cause mortality in patients with chronic heart failure (HF). This finding suggests PDW can aid in risk stratification for chronic HF patients.

Area of Science:

  • Cardiology
  • Hematology
  • Clinical Medicine

Background:

  • Platelet distribution width (PDW) predicts adverse outcomes in acute myocardial infarction and acute heart failure (HF).
  • The prognostic value of PDW in chronic HF remains largely unexplored.

Purpose of the Study:

  • To investigate the association between PDW levels and all-cause mortality in patients with chronic HF.

Main Methods:

  • Retrospective analysis of 766 outpatients with chronic HF and left ventricular systolic dysfunction (LVSD).
  • Multivariable Cox regression was used to assess the relationship between PDW and mortality, adjusting for clinical factors and biomarkers.
  • Exclusion criteria included missing PDW data or preserved/recovered ejection fraction.

Main Results:

  • The median PDW was 13.5 fL. During a median follow-up of 49 months, 48.6% of patients died.
  • Patients with PDW ≥ 14.3 fL had a 32% higher risk of all-cause death (HR: 1.32, 95% CI: 1.05-1.64) compared to those with lower PDW.
  • This association remained significant after multivariate adjustment.

Conclusions:

  • Elevated PDW (≥ 14.3 fL) is an independent predictor of mortality in chronic HF patients.
  • PDW offers a practical, inexpensive, and accessible parameter for risk stratification in chronic HF.
  • Clinicians can utilize PDW to better identify high-risk individuals within a chronic HF population.
Abstract